GSK secured FDA approval for an inflammatory disease drug that it says could reach £3 billion ($4 billion) in peak sales. The agency greenlit depemokimab

Bristol Myers Squibb is the latest large pharma to tap into the speed and efficiency of drug R&D in China. The New York drug giant

DBV Technologies said its peanut allergy patch succeeded in a Phase 3 trial, setting the company up for another FDA submission after a drawn-out saga

FDA Commissioner Marty Makary offered a softer version of the FDA’s view of Covid-19 vaccines than emerged in a recent internal memo, saying that the

Verge Genomics’ sole clinical-stage drug has failed, and the California biotech will shift to a partnership model for its AI-driven discovery platform, Endpoints News has